A research study with the goal of finding a new treatment for Alzheimer’s disease is moving into Stage 2 of the trial.

Microsoft co-founder Bill Gates reflects on his father's Alzheimer's battle and expresses optimism about advancements in ...

In searching for a possible therapeutic target to stop the progress of this disease, an international scientific team, led by ...

A major global study tested whether European-derived polygenic risk scores (PGS) for Alzheimer’s disease can predict risk ...

The UK's state-run health service said Thursday it will not offer two new treatments for Alzheimer's disease, citing high ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s ...

One of the most common genes associated with Alzheimer's has now been linked to loss of smell. The discovery may offer a new ...

The progressive brain condition affects memory, thinking, behaviour and emotion, but there are some early physical signs that ...

Jim Rogers, 58, was living and working in Australia when he started to develop symptoms of the incurable neurological ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

After presentations to the International Linked Clinical Trials (iLCT), which was set up by Cure Parkinson’s over a decade ...